INDV
Indivior Pharmaceuticals Inc
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$34.94
+0.32%Margins
Gross margin
83.9%
EBITDA margin
32.4%
EBIT margin
38.9%
Net margin
26.7%
FCF margin
-8.3%
-170.7%
Return on equity
28.8%
Return on assets
172.1%
Return on invested capital
1.10x
Asset turnover
-$40.0M
Cash from operations
$1.88
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026